PharmaPoint: Multiple Sclerosis - Current and Future Players



Summary



GlobalData has released its pharma report, “PharmaPoint: Multiple Sclerosis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Multiple Sclerosis Market. The report identifies and analyses the key companies shaping and driving the global Multiple Sclerosis market. The report provides insight into the competitive Multiple Sclerosis landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.



Scope


- Investigation of current and future market competition for Multiple Sclerosis
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the Multiple Sclerosis sector through market impact analysis, future market scenario and company analysis



Reasons to buy


- Gain a high level view of the trends shaping and driving the Multiple Sclerosis Market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What’s the next big thing in the global Multiple Sclerosis market landscape? Identify, understand and capitalize

Table Of Contents

Table of Contents

1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 9
3 Market Outlook 11
3.1 Global Markets 11
3.1.1 Forecast 11
3.1.2 Drivers and Barriers - Global Issues 13
4 Current and Future Players 17
4.1 Overview 17
4.2 Trends in Corporate Strategy 19
4.3 Company Profiles 21
4.3.1 Biogen Idec 21
4.3.2 Teva Pharmaceutical Industries 24
4.3.3 Merck Serono (EMD Serono) 27
4.3.4 Sanofi 30
4.3.5 Bayer HealthCare Pharmaceuticals 33
4.3.6 Novartis International 35
4.3.7 Hoffmann-La Roche 38
4.3.8 GlaxoSmithKline 40
5 Appendix 42
5.1 Bibliography 42
5.2 Abbreviations 42
5.3 Methodology 43
5.4 Forecasting Methodology 43
5.4.1 Diagnosed MS patients 43
5.4.2 Percent Drug-Treated Patients 44
5.4.3 Drugs Included in Each Therapeutic Class 44
5.4.4 Launch and Patent Expiry Dates 45
5.4.5 General Pricing Assumptions 46
5.4.6 Individual Drug Assumptions 47
5.4.7 Generic Erosion 50
5.4.8 Pricing of Pipeline agents 51
5.5 Physicians and Specialists Included in This Report 52
5.6 Primary Research - Prescriber Survey 53
5.7 About the Authors 53
5.7.1 Analysts 53
5.7.2 Global Head of Healthcare 54
5.8 About GlobalData 55
5.9 Contact Us 55
5.10 Disclaimer 55



List of Tables

Table 1: Global Sales Forecasts ($m) for Multiple Sclerosis, 2012-2022 12
Table 2: Global Multiple Sclerosis Market - Drivers and Barriers, 2012 13
Table 3: Key Companies in the Multiple Sclerosis Market, 2012 18
Table 4: Biogen’s Multiple Sclerosis Portfolio Assessment, 2012 22
Table 5: Biogen SWOT Analysis, 2012 23
Table 6: Teva’s Multiple Sclerosis Portfolio Assessment, 2012 25
Table 7: Teva SWOT Analysis, 2012 26
Table 8: Merck’s Multiple Sclerosis Portfolio Assessment, 2012 28
Table 9: Merck SWOT Analysis, 2012 29
Table 10: Sanofi’s Multiple Sclerosis Portfolio Assessment, 2012 31
Table 11: Sanofi SWOT Analysis, 2012 32
Table 12: Bayer’s Multiple Sclerosis Portfolio Assessment, 2012 34
Table 13: Bayer SWOT Analysis, 2012 34
Table 14: Novartis’ Multiple Sclerosis Portfolio Assessment, 2012 36
Table 15: Novartis SWOT Analysis, 2012 37
Table 16: Roche’s Multiple Sclerosis Portfolio Assessment, 2012 39
Table 17: Roche SWOT Analysis, 2012 39
Table 18: GlaxoSmithKiline’s Multiple Sclerosis Portfolio Assessment, 2012 41
Table 19: GlaxoSmithKline SWOT Analysis, 2012 41
Table 20: Key Launch Dates 45
Table 21: Key Patent Expiries 45
Table 22: Physicians Surveyed, By Country 53



List of Figures

Figure 1: Global Market Sales for Multiple Sclerosis by Region, 2012-2022 13
Figure 2: Company Portfolio Gap Analysis in Multiple Sclerosis, 2012-2022 20



Companies Mentioned

Biogen Idec
Teva Pharmaceutical Industries
Merck Serono (EMD Serono)
Sanofi
Bayer HealthCare Pharmaceuticals
Novartis International
Hoffmann-La Roche
GlaxoSmithKline

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Analysis of the Global Infectious Disease Diagnostics Market

Analysis of the Global Infectious Disease Diagnostics Market

  • $ 10 000
  • Industry report
  • September 2014
  • by Frost & Sullivan

Molecular Methods Present Significant Opportunities This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast ...

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • July 2014
  • by GBI Research

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical ...

Blood-Brain Barrier Technologies and Global Markets

Blood-Brain Barrier Technologies and Global Markets

  • $ 6 650
  • Industry report
  • July 2014
  • by BCC Research

This BCC Research report analyzes the current status of the global therapeutic market for blood-brain barrier (BBB) technologies, including its growth potential, determines its current market status, examines ...

Bcc Research Bitopertin Forecast

August 2014 $ 5 500

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.